SCHEMBL19079191

SCHEMBL19079191

CC(C)(C)C(N)c1ccc(NC(=O)c2cc(C3CC3)on2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.57
NPC1 O15118 4/20 0.57
SMN1; SMN2 Q16637 4/20 0.57
TP53 P04637 1/20 0.57
STAT1 P42224 4/20 0.56
TSHR P16473 1/20 0.53
STAT3 P40763 3/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
CASP3 P42574 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
LMNA P02545 1/20 0.49
POLB P06746 1/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SMYD3 Q9H7B4 4/20 0.48
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079196 0.88 RAB9A (0.57) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL19079168 0.88 RAB9A (0.59) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL19079190 0.85 RAB9A (0.56) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL19079313 0.84 RAB9A (0.60) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL17594445 0.81 RAB9A (0.65) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL19079278 0.80 RAB9A (0.53) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL19079183 0.80 SMYD3 (0.52) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL17731992 0.79 STAT1 (0.67) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL19079456 0.79 SMYD3 (0.65) RAB9ANPC1SMN1; SMN2TP53STAT1
SCHEMBL19079460 0.78 RAB9A (0.61) RAB9ANPC1SMN1; SMN2TP53STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200148650-A1 ISOXAZOLE CARBOXAMIDE COMPOUNDS Epizyme, Inc. 2020-05-14 US disclosed
US-10428029-B2 Isoxazole carboxamide compounds Epizyme, Inc. (US) 2019-10-01 US disclosed
US-20170190676-A1 Isoxazole Carboxamide Compounds Epizyme, Inc. (US) 2017-07-06 US disclosed
US-20170190676-A1 Isoxazole Carboxamide Compounds Epizyme, Inc. (US) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10428029-B2 Isoxazole carboxamide compounds SMYD3, SMYD2, SNRPD3 RAB9A 759/4885NPC1 3888/4885SMN1; SMN2 248/4885
US-20170190676-A1 Isoxazole Carboxamide Compounds SMYD3, SMYD2, SNRPD3 RAB9A 759/4885NPC1 3888/4885SMN1; SMN2 248/4885
US-20200148650-A1 ISOXAZOLE CARBOXAMIDE COMPOUNDS SMYD3, SMYD2, SNRPD3 RAB9A 705/4885NPC1 3842/4885SMN1; SMN2 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.